Skip to main content
KTTA logo

KTTA · Pasithea Therapeutics Corp.

Track KTTA — free
$0.56 +0.01 (+0.99%) At close · Aug 28
Market Cap
$18.53M
Shares
33.41M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

KTTA Short Interest Forecast

Equibles' model estimates 255,493 shares sold short for the August 31, 2026 settlement, +0.6% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
255,493 +0.6% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 253,936 196,600 +57,336 1.29
2026-07-31 196,600 242,873 -46,273 1.00
2026-07-15 242,873 287,315 -44,442 1.00
2026-06-30 287,315 311,708 -24,393 1.00
2026-06-15 311,708 274,584 +37,124 1.00
2026-05-29 274,584 297,457 -22,873 1.00
2026-05-15 297,457 267,043 +30,414 1.00
2026-04-30 267,043 227,972 +39,071 1.00
2026-04-15 227,972 122,487 +105,485 1.00
2026-03-31 122,487 194,443 -71,956 1.00
2026-03-13 194,443 173,570 +20,873 2.87
2026-02-27 173,570 183,118 -9,548 1.31
2026-02-13 183,118 264,669 -81,551 1.17
2026-01-30 264,669 366,534 -101,865 2.18
2026-01-15 366,534 559,624 -193,090 1.29
2025-12-31 559,624 452,180 +107,444 1.39
2025-12-15 452,180 3,857,828 -3,405,648 1.00
2025-11-28 3,857,828 23,343 +3,834,485 1.00
2025-11-14 23,343 38,606 -15,263 1.00
2025-10-31 38,606 22,916 +15,690 1.00
2025-10-15 22,916 21,917 +999 1.00
2025-09-30 21,917 55,971 -34,054 1.00
2025-09-15 55,971 100,220 -44,249 1.00
2025-08-29 100,220 32,574 +67,646 1.00

Full FINRA short interest reporting calendar

Showing 1–24 of 24 settlements
Key facts CIK 1841330 CUSIP 70261F202 13F (30d) 32 filings 31 filers Visit website Investor relations